Research programme: glucagon and glucagon-like peptide-1 agonists - Arecor

Drug Profile

Research programme: glucagon and glucagon-like peptide-1 agonists - Arecor

Alternative Names: Aqueous Liraglutide - Arecor; Liraglutide - Arecor; Stable aqueous glucagon - Arecor

Latest Information Update: 21 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Arecor
  • Class Glucagon-like peptides; Peptide hormones; Peptides
  • Mechanism of Action Glucagon like peptide 1 receptor agonists; Glucagon receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Diabetes mellitus

Most Recent Events

  • 15 Sep 2016 Preclinical trials in Diabetes mellitus in United Kingdom (Parenteral) before September 2016 (Arecor pipeline, September 2016)
  • 15 Sep 2016 Arecor has patent protection for aqueous glucagon in (Arecor pipeline, September 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top